NEUROFIBROMA PLEXIFORM
Clinical trials for NEUROFIBROMA PLEXIFORM explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMA PLEXIFORM trials appear
Sign up with your email to follow new studies for NEUROFIBROMA PLEXIFORM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests pill to shrink painful NF1 tumors
Disease control OngoingThis early-stage study is testing the safety and effects of an oral medication called selumetinib in Chinese children and adults with neurofibromatosis type 1 (NF1) who have inoperable plexiform neurofibromas (tumors). Participants take the medication twice daily until their dise…
Matched conditions: NEUROFIBROMA PLEXIFORM
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tracking a lifeline: Real-World look at drug for Kids' debilitating tumors
Disease control OngoingThis study aims to understand how well the drug selumetinib works and how safe it is for children in China with a genetic condition called NF1, which causes painful, inoperable nerve tumors. It will follow about 80-100 children already receiving this approved treatment in real-wo…
Matched conditions: NEUROFIBROMA PLEXIFORM
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for kids with untreatable tumors
Disease control OngoingThis study tested an oral drug called selumetinib for children and young adults with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The main goals were to find a safe dose and see if the drug could shrink or stop these tumors from growing.…
Matched conditions: NEUROFIBROMA PLEXIFORM
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC